In collaboration with the Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Icentia is embarking on a clinical study to evaluate the CardioStatTM, a unique electrocardiography solution for patients with suspected cardiac arrhythmia.
Specifically, the study will evaluate the performance of the CardioStatTM electrocardiography monitor and its efficacy at detecting most common types of atrial arrhythmias. In a three-phase, 2-year multi-center clinical study, set to begin this spring, approximately 300 patients will be enrolled and followed for suspected arrhythmia with the CardioStatTM electrocardiography monitor.
The study will be under the supervision of cardiologist Dr Isabelle Nault from IUCPQ. Dr Nault is the Principal Investigator. She will also be receiving the support from a group of six other cardiologists from IUCPQ. This study was made possible with the financial support of the Fondation de l'IUCPQ.
IUCPQ's mission is to stop epidemic obesity and the progression of cardiac and pulmonary diseases. Learn more at http://www.iucpq.qc.ca.